Eliza C. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eliza C. Miller has a total of 385 co-authors. Here are the top co-authors by number of shared publications:
- Natalie A. Bello
Department of Cardiology, Cedars Sinai Medical Center, Los Angeles, CA (N.A.B.).
9 shared publications Amelia K. Boehme
Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
8 shared publicationsNoora Haghighi
Department of Neurology Columbia University Irving Medical Center New York New York USA
8 shared publications- Amelia K. Boehme
Department of Neurology, Columbia University School of Medicine, New York, NY (S.P., A.K.B.).
7 shared publications - Joshua Zebadiah Willey
Department of Neurology, Columbia University Medical Center, New York, NY (J.Z.W.).
7 shared publications - Randolph S. Marshall
Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
7 shared publications
Latest Publications
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e035681
Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis
Background: Adverse pregnancy outcomes (APOs) are associated with increased hypertension risk. Black women experience higher rates of APOs and hypertension compared with White women, but whether APOs contribute to Black‐White hypertension disparities remains unknown. Methods: The nuMoM2b‐HHS (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers‐To‐Be–Heart Health Study) prospectively recruited nulliparous pregnant people at 8 US centers (2010–2013) with follow‐up 2 to 7 years postpartum (2014–2017). Race, which represents a social construct, was self‐identified. The primary outcome was incident hypertension at follow‐up. APOs included hypertensive disorders of pregnancy, preterm birth, and small‐for‐gestational age birth. Potential confounders (psychological health, social factors, and health behaviors) were assessed via validated questionnaires. We used targeted maximum likelihood‐based estimation to estimate Black‐White hypertension differences that would remain if racial disparities in APOs were eliminated. Results: Among 3335 participants (17% Black; 83% White; mean [SD] age, 27.6 [5.1] years), APO incidence was higher in Black versus White individuals (rate differences [RDs] per 1000 births: hypertensive disorders of pregnancy: 52.5 [95% CI, 20.0–85.1]; preterm birth: 45.4 [95% CI, 20.8–70.1]; small‐for‐gestational age: 102.4 [95% CI, 75.8–129.1]). Incident hypertension at median 3 years postpartum was higher in Black versus White individuals (RD, 107.1 [95% CI, 69.6–144.4]). APOs mediated the racial disparity in hypertension; eliminating Black‐White disparities in APOs would decrease the Black‐White disparity in hypertension by 18.2% for hypertensive disorders of pregnancy (RD, 87.6 [95% CI, 36.1–139.2]), 16.3% for preterm birth (RD, 89.6 [95% CI, 41.7–137.6]), and 13.9% for small‐for‐gestational age (RD, 92.2 [95% CI, 41.6–142.9]). Conclusions: Black‐White differences in hypertension were partially mediated by APOs. APOs may represent a pregnancy‐specific pathway contributing to racial disparities in hypertension.
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e035681
Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis
Background: Adverse pregnancy outcomes (APOs) are associated with increased hypertension risk. Black women experience higher rates of APOs and hypertension compared with White women, but whether APOs contribute to Black‐White hypertension disparities remains unknown. Methods: The nuMoM2b‐HHS (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers‐To‐Be–Heart Health Study) prospectively recruited nulliparous pregnant people at 8 US centers (2010–2013) with follow‐up 2 to 7 years postpartum (2014–2017). Race, which represents a social construct, was self‐identified. The primary outcome was incident hypertension at follow‐up. APOs included hypertensive disorders of pregnancy, preterm birth, and small‐for‐gestational age birth. Potential confounders (psychological health, social factors, and health behaviors) were assessed via validated questionnaires. We used targeted maximum likelihood‐based estimation to estimate Black‐White hypertension differences that would remain if racial disparities in APOs were eliminated. Results: Among 3335 participants (17% Black; 83% White; mean [SD] age, 27.6 [5.1] years), APO incidence was higher in Black versus White individuals (rate differences [RDs] per 1000 births: hypertensive disorders of pregnancy: 52.5 [95% CI, 20.0–85.1]; preterm birth: 45.4 [95% CI, 20.8–70.1]; small‐for‐gestational age: 102.4 [95% CI, 75.8–129.1]). Incident hypertension at median 3 years postpartum was higher in Black versus White individuals (RD, 107.1 [95% CI, 69.6–144.4]). APOs mediated the racial disparity in hypertension; eliminating Black‐White disparities in APOs would decrease the Black‐White disparity in hypertension by 18.2% for hypertensive disorders of pregnancy (RD, 87.6 [95% CI, 36.1–139.2]), 16.3% for preterm birth (RD, 89.6 [95% CI, 41.7–137.6]), and 13.9% for small‐for‐gestational age (RD, 92.2 [95% CI, 41.6–142.9]). Conclusions: Black‐White differences in hypertension were partially mediated by APOs. APOs may represent a pregnancy‐specific pathway contributing to racial disparities in hypertension.
- 24 June 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2531-2541
Menopause and Its Implications for Stroke in Women
Stroke is the third leading cause of death in women and a major driver of disability. Menopause is a universal transition for midlife women, which is accompanied by menstrual cycle changes, hormonal fluctuations, and, for many women, the occurrence of menopausal symptoms. An accumulating body of research underscores the importance of menopause and its features to stroke risk in women, including the type and timing of menopause, endogenous hormone profiles, and menopausal symptoms, including vasomotor symptoms and sleep problems. In addition, menopausal hormone therapy, a leading approach to managing menopausal symptoms, has implications for stroke risk, which varies depending on the menopausal hormone therapy formulation, route of delivery, and the age and health of the recipient, with transdermal menopausal hormone therapy formulations administered to younger midlife women showing a more favorable profile. This review summarizes the data linking menopause and stroke, and offers suggestions to inform clinical decision-making. Knowledge gaps and directions for future research are highlighted.
- 24 June 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2531-2541
Menopause and Its Implications for Stroke in Women
Stroke is the third leading cause of death in women and a major driver of disability. Menopause is a universal transition for midlife women, which is accompanied by menstrual cycle changes, hormonal fluctuations, and, for many women, the occurrence of menopausal symptoms. An accumulating body of research underscores the importance of menopause and its features to stroke risk in women, including the type and timing of menopause, endogenous hormone profiles, and menopausal symptoms, including vasomotor symptoms and sleep problems. In addition, menopausal hormone therapy, a leading approach to managing menopausal symptoms, has implications for stroke risk, which varies depending on the menopausal hormone therapy formulation, route of delivery, and the age and health of the recipient, with transdermal menopausal hormone therapy formulations administered to younger midlife women showing a more favorable profile. This review summarizes the data linking menopause and stroke, and offers suggestions to inform clinical decision-making. Knowledge gaps and directions for future research are highlighted.
- Open Access
- 19 June 2026
- Published by SAGE Publications in International Journal of Stroke
Stroke in Pregnancy
Maternal stroke, while rare, leads to significant maternal morbidity and mortality. Physiologic changes in pregnancy and the postpartum period disrupt cerebrovascular homeostasis, predisposing to pregnancy specific syndromes and tripling stroke risk. Mechanisms of pregnancy related stroke are diverse and include cardioembolism, vasculopathies (cervical artery dissections, reversible cerebral vasoconstriction syndrome), intracranial hemorrhage related to vascular lesions or preeclampsia, and cerebral venous thrombosis. Heterogeneity of presentation and limited experience treating pregnant women can contribute to challenges in diagnosis and management. This article reviews physiologic changes of pregnancy, as well as pregnancy associated syndromes that predispose to stroke, including preeclampsia and other hypertensive disorders of pregnancy, peripartum cardiomyopathy, and amniotic fluid embolism. We propose that hypertensive disorders of pregnancy and certain types of pregnancy related stroke may share underlying mechanisms and represent a continuum of pregnancy-associated vasculopathy characterized by endothelial dysfunction and sympathetic hyperactivity. We also offer practical considerations for stroke clinicians, including safety of imaging modalities, therapeutic options both for prevention and treatment of pregnancy-related stroke, and prognosis after pregnancy associated stroke.
- 19 June 2026
- Published by SAGE Publications in International Journal of Stroke
Open AccessStroke in Pregnancy
Maternal stroke, while rare, leads to significant maternal morbidity and mortality. Physiologic changes in pregnancy and the postpartum period disrupt cerebrovascular homeostasis, predisposing to pregnancy specific syndromes and tripling stroke risk. Mechanisms of pregnancy related stroke are diverse and include cardioembolism, vasculopathies (cervical artery dissections, reversible cerebral vasoconstriction syndrome), intracranial hemorrhage related to vascular lesions or preeclampsia, and cerebral venous thrombosis. Heterogeneity of presentation and limited experience treating pregnant women can contribute to challenges in diagnosis and management. This article reviews physiologic changes of pregnancy, as well as pregnancy associated syndromes that predispose to stroke, including preeclampsia and other hypertensive disorders of pregnancy, peripartum cardiomyopathy, and amniotic fluid embolism. We propose that hypertensive disorders of pregnancy and certain types of pregnancy related stroke may share underlying mechanisms and represent a continuum of pregnancy-associated vasculopathy characterized by endothelial dysfunction and sympathetic hyperactivity. We also offer practical considerations for stroke clinicians, including safety of imaging modalities, therapeutic options both for prevention and treatment of pregnancy-related stroke, and prognosis after pregnancy associated stroke.
- 9 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8)
Subtypes of Hypertension 2 to 7 Years After First Pregnancy
BACKGROUND: Isolated diastolic hypertension can precede combined systolic-diastolic hypertension, suggesting isolated diastolic hypertension may be a risk factor for adverse cardiovascular outcomes. Little is known about the prevalence of hypertensive subtypes (isolated diastolic, isolated systolic, or combined systolic-diastolic hypertension) in the years after first pregnancy, and whether these differ after hypertensive disorder of pregnancy. METHODS: This is a secondary analysis (conducted 2023–2024) of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study. Nulliparas were enrolled at 8 US clinical sites from 2010 to 2013; participants who completed the Heart Health Study visit 2 to 7 years after pregnancy were eligible. Blood pressures were elevated at the visit if systolic was ≥130 mm Hg and diastolic ≥80 mm Hg. Multinomial logistic regression relative risk models were adjusted for age, body mass index, race, and time from pregnancy to visit. RESULTS: Four thousand three hundred two participants were included. Mean age at Heart Health Study visit was 30.7 years (SD, 5.6 years); 812 (19%) had elevated blood pressure. Isolated diastolic hypertension was most prevalent (n=627; 15%). Compared with normotensive pregnancy, hypertensive disorders of pregnancy were associated with combined systolic-diastolic (adjusted risk ratio, 3.09 [95% CI, 2.21–4.31]) and isolated diastolic hypertension (adjusted risk ratio, 1.65 [95% CI, 1.36–2.00]). CONCLUSIONS: Isolated diastolic hypertension is the most prevalent hypertensive subtype after first pregnancy. Women with hypertensive disorders of pregnancy had increased risk of combined systolic-diastolic and isolated diastolic hypertension. Given the high prevalence of isolated diastolic hypertension found in this cohort, postpartum women represent a subgroup with opportunity for cardiovascular risk reduction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02231398.
- 9 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (8)
Subtypes of Hypertension 2 to 7 Years After First Pregnancy
BACKGROUND: Isolated diastolic hypertension can precede combined systolic-diastolic hypertension, suggesting isolated diastolic hypertension may be a risk factor for adverse cardiovascular outcomes. Little is known about the prevalence of hypertensive subtypes (isolated diastolic, isolated systolic, or combined systolic-diastolic hypertension) in the years after first pregnancy, and whether these differ after hypertensive disorder of pregnancy. METHODS: This is a secondary analysis (conducted 2023–2024) of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be Heart Health Study. Nulliparas were enrolled at 8 US clinical sites from 2010 to 2013; participants who completed the Heart Health Study visit 2 to 7 years after pregnancy were eligible. Blood pressures were elevated at the visit if systolic was ≥130 mm Hg and diastolic ≥80 mm Hg. Multinomial logistic regression relative risk models were adjusted for age, body mass index, race, and time from pregnancy to visit. RESULTS: Four thousand three hundred two participants were included. Mean age at Heart Health Study visit was 30.7 years (SD, 5.6 years); 812 (19%) had elevated blood pressure. Isolated diastolic hypertension was most prevalent (n=627; 15%). Compared with normotensive pregnancy, hypertensive disorders of pregnancy were associated with combined systolic-diastolic (adjusted risk ratio, 3.09 [95% CI, 2.21–4.31]) and isolated diastolic hypertension (adjusted risk ratio, 1.65 [95% CI, 1.36–2.00]). CONCLUSIONS: Isolated diastolic hypertension is the most prevalent hypertensive subtype after first pregnancy. Women with hypertensive disorders of pregnancy had increased risk of combined systolic-diastolic and isolated diastolic hypertension. Given the high prevalence of isolated diastolic hypertension found in this cohort, postpartum women represent a subgroup with opportunity for cardiovascular risk reduction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02231398.
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e043159
Sex Differences in Young Adult Stroke Severity Using Linked Colorado—All Payer's Claims Database and the Get With The Guidelines‐Stroke Registry
Background: More young women than men experience first‐time strokes. This may be from improved detection of milder severity strokes in young women, as they are more likely to present with nondebilitating neurologic symptoms than men. Methods: The objective was to examine sex differences in stroke severity among young adults. Young adults (18–55) with index stroke (January 1, 2012–April 3, 2019) were identified, using Colorado All Payer's Claims Database and linked to the GWTG (Get With The Guidelines)‐Stroke Registry. Records were reviewed based on 5/5 linked identifiers (±1 day for admission/discharge dates, date of birth, sex, and hospital), then on 4/5 linked identifiers. Stroke severity based on National Institutes of Health Stroke Scale score was extracted from GWTG‐stroke. Logistic regression models were used to calculate odds ratios (OR) of having a mild severity stroke (National Institutes of Health Stroke Scale score ≤5) by sex in ages 18 to 45 and 46 to 55 years. Results: Colorado All Payer's Claims Database captured 3029 stroke cases; 2732 from hospitals that reported to GWTG‐Stroke; 1597 (58.7%) linked at least 4/5 identifiers; 1311 with National Institutes of Health Stroke Scale score (50.2% women, 80% ischemic). Women were younger (mean age 45.4 years, men 46.9 years, P =0.001), had lower blood pressure (median 143/85, men 150/91, P P P =0.02) but not in 46–55 (OR, 1.02 [95% CI, 0.5–2.08]). There was no difference in ischemic stroke severity by sex in either age group. Conclusions: Young women with index strokes did not present with more milder severity strokes compared with men.
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e043159
Open AccessSex Differences in Young Adult Stroke Severity Using Linked Colorado—All Payer's Claims Database and the Get With The Guidelines‐Stroke Registry
Background: More young women than men experience first‐time strokes. This may be from improved detection of milder severity strokes in young women, as they are more likely to present with nondebilitating neurologic symptoms than men. Methods: The objective was to examine sex differences in stroke severity among young adults. Young adults (18–55) with index stroke (January 1, 2012–April 3, 2019) were identified, using Colorado All Payer's Claims Database and linked to the GWTG (Get With The Guidelines)‐Stroke Registry. Records were reviewed based on 5/5 linked identifiers (±1 day for admission/discharge dates, date of birth, sex, and hospital), then on 4/5 linked identifiers. Stroke severity based on National Institutes of Health Stroke Scale score was extracted from GWTG‐stroke. Logistic regression models were used to calculate odds ratios (OR) of having a mild severity stroke (National Institutes of Health Stroke Scale score ≤5) by sex in ages 18 to 45 and 46 to 55 years. Results: Colorado All Payer's Claims Database captured 3029 stroke cases; 2732 from hospitals that reported to GWTG‐Stroke; 1597 (58.7%) linked at least 4/5 identifiers; 1311 with National Institutes of Health Stroke Scale score (50.2% women, 80% ischemic). Women were younger (mean age 45.4 years, men 46.9 years, P =0.001), had lower blood pressure (median 143/85, men 150/91, P P P =0.02) but not in 46–55 (OR, 1.02 [95% CI, 0.5–2.08]). There was no difference in ischemic stroke severity by sex in either age group. Conclusions: Young women with index strokes did not present with more milder severity strokes compared with men.
- Top Cited Papers
- 10 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (3) , e214577
Autoregulation-Guided Blood Pressure Targets After Stroke Thrombectomy
The optimal blood pressure (BP) target after endovascular thrombectomy (EVT) remains elusive. The aim of our study was to assess the relationship between individualized autoregulation-based BP thresholds, secondary brain injury, and functional outcomes. We conducted a prospective observational study of patients with acute ischemic stroke who underwent EVT. Simultaneous recordings of arterial BP and near-infrared spectroscopy were used to continuously monitor each patient's limits of autoregulation for up to 24 hours. Time outside limits of autoregulation was correlated with short-term clinical end points, radiographic biomarkers of secondary brain injury, and functional outcomes. Personalized BP targets were successfully computed in 199 patients. Percent time outside limits of autoregulation was independently associated with early neurologic deterioration (OR 1.2, 95% CI 1.1-1.4, p < 0.001) and worse modified Rankin Scale scores at 90 days (OR 1.22, 95% CI 1.09-1.36, p < 0.001). Patients with hemorrhagic transformation and symptomatic intracranial hemorrhage spent significantly more time above the upper limit of autoregulation compared with those without (18.7% vs 11%, p = 0.02, and 24.9% vs 12.3%, p = 0.024, respectively). Furthermore, time above the upper limit of autoregulation was correlated with net water uptake, a radiographic biomarker of cerebral edema (β = 1.6, 95% CI 0.4-2.8, p = 0.009). In nonrecanalized patients, every 60 minutes below the lower limit of autoregulation was associated with an infarct progression of 16.2 mL (p < 0.001). Deviations from personalized BP targets were associated with an increased risk of secondary brain injury and worse functional outcomes. The study proposes autoregulation-oriented BP management as a promising strategy for improving recovery after ischemic stroke.
- 10 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (3) , e214577
Top Cited PapersAutoregulation-Guided Blood Pressure Targets After Stroke Thrombectomy
The optimal blood pressure (BP) target after endovascular thrombectomy (EVT) remains elusive. The aim of our study was to assess the relationship between individualized autoregulation-based BP thresholds, secondary brain injury, and functional outcomes. We conducted a prospective observational study of patients with acute ischemic stroke who underwent EVT. Simultaneous recordings of arterial BP and near-infrared spectroscopy were used to continuously monitor each patient's limits of autoregulation for up to 24 hours. Time outside limits of autoregulation was correlated with short-term clinical end points, radiographic biomarkers of secondary brain injury, and functional outcomes. Personalized BP targets were successfully computed in 199 patients. Percent time outside limits of autoregulation was independently associated with early neurologic deterioration (OR 1.2, 95% CI 1.1-1.4, p < 0.001) and worse modified Rankin Scale scores at 90 days (OR 1.22, 95% CI 1.09-1.36, p < 0.001). Patients with hemorrhagic transformation and symptomatic intracranial hemorrhage spent significantly more time above the upper limit of autoregulation compared with those without (18.7% vs 11%, p = 0.02, and 24.9% vs 12.3%, p = 0.024, respectively). Furthermore, time above the upper limit of autoregulation was correlated with net water uptake, a radiographic biomarker of cerebral edema (β = 1.6, 95% CI 0.4-2.8, p = 0.009). In nonrecanalized patients, every 60 minutes below the lower limit of autoregulation was associated with an infarct progression of 16.2 mL (p < 0.001). Deviations from personalized BP targets were associated with an increased risk of secondary brain injury and worse functional outcomes. The study proposes autoregulation-oriented BP management as a promising strategy for improving recovery after ischemic stroke.
- Open Access
Association between preeclampsia and reversible cerebral vasoconstriction syndrome: A case‐control study
Background and objectives: Pregnancy‐related reversible cerebral vasoconstriction syndrome (RCVS) has higher rates of intracerebral complications and mortality compared to non‐pregnant RCVS. Case reports suggest preeclampsia‐eclampsia as an important risk factor; however, data are limited regarding this association. We hypothesized that pregnancy‐related RCVS is strongly associated with preeclampsia‐eclampsia. Methods: We performed a single‐center, retrospective, case‐control study to estimate the association between preeclampsia‐eclampsia and RCVS. Cases between January 1, 2010, and June 30, 2024, were identified from hospital billing data and defined as RCVS in pregnancy or postpartum (p < 0.001) and preeclampsia‐eclampsia (73% vs. 10%, p < 0.001) were more prevalent in cases compared to controls. Most RCVS (80%) and preeclampsia‐eclampsia (62%) occurred postpartum. Antepartum RCVS occurred at a median of 30 weeks (interquartile range [IQR] 20–33). Fifty‐five percent of RCVS cases had associated intracranial complications such as hemorrhage, infarction, or posterior reversible encephalopathy syndrome, 45% required intensive care, and 15% were discharged to rehabilitation. Adjusting for gravidity, pregnancy length, and timing of preeclampsia‐eclampsia diagnosis (antepartum, intrapartum, or postpartum), preeclampsia‐eclampsia was associated with increased odds of RCVS (adjusted OR [aOR], 37.1; 95% CI, 10.6–129.9; p < 0.001). The fraction of RCVS attributable to preeclampsia‐eclampsia was 95%. Discussion: Preeclampsia‐eclampsia is associated with increased odds of pregnancy‐related RCVS, suggesting possible shared mechanisms. Prospective studies of preeclampsia‐eclampsia patients, including neurovascular imaging, are needed to confirm these findings and explore the underlying pathophysiology.
Open AccessAssociation between preeclampsia and reversible cerebral vasoconstriction syndrome: A case‐control study
Background and objectives: Pregnancy‐related reversible cerebral vasoconstriction syndrome (RCVS) has higher rates of intracerebral complications and mortality compared to non‐pregnant RCVS. Case reports suggest preeclampsia‐eclampsia as an important risk factor; however, data are limited regarding this association. We hypothesized that pregnancy‐related RCVS is strongly associated with preeclampsia‐eclampsia. Methods: We performed a single‐center, retrospective, case‐control study to estimate the association between preeclampsia‐eclampsia and RCVS. Cases between January 1, 2010, and June 30, 2024, were identified from hospital billing data and defined as RCVS in pregnancy or postpartum (p < 0.001) and preeclampsia‐eclampsia (73% vs. 10%, p < 0.001) were more prevalent in cases compared to controls. Most RCVS (80%) and preeclampsia‐eclampsia (62%) occurred postpartum. Antepartum RCVS occurred at a median of 30 weeks (interquartile range [IQR] 20–33). Fifty‐five percent of RCVS cases had associated intracranial complications such as hemorrhage, infarction, or posterior reversible encephalopathy syndrome, 45% required intensive care, and 15% were discharged to rehabilitation. Adjusting for gravidity, pregnancy length, and timing of preeclampsia‐eclampsia diagnosis (antepartum, intrapartum, or postpartum), preeclampsia‐eclampsia was associated with increased odds of RCVS (adjusted OR [aOR], 37.1; 95% CI, 10.6–129.9; p < 0.001). The fraction of RCVS attributable to preeclampsia‐eclampsia was 95%. Discussion: Preeclampsia‐eclampsia is associated with increased odds of pregnancy‐related RCVS, suggesting possible shared mechanisms. Prospective studies of preeclampsia‐eclampsia patients, including neurovascular imaging, are needed to confirm these findings and explore the underlying pathophysiology.
- Top Cited Papers
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 292-300
Identifying Missed Diagnostic Opportunities in Maternal Stroke
BACKGROUND: Pregnancy-associated stroke may present with nonfocal symptoms, leading to missed diagnostic opportunities (MDO). METHODS: We conducted a retrospective study including patients aged 18 to 50 years and pregnant or within 1 year of delivery, treated at 5 US comprehensive stroke centers from 2012 to 2021 for confirmed arterial ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, or cerebral venous thrombosis. Vascular neurologists at each site reviewed cases using a validated tool, Safer Stroke-Dx. We determined the proportion of cases with MDO and estimated 95% CIs based on a binomial distribution. RESULTS: We identified 135 patients with pregnancy-related stroke (mean age, 32.4 [SD, 6.0] years), of whom 37 (27%) had MDO (95% CI, 20.6%–35.5%). Presenting symptoms included focal neurological deficits (57%; n=77), headache (53%; n=71), systemic symptoms (26%; n=35), and altered mental status (19%; n=25). More patients with MDO had hemorrhagic strokes (22 of 37 [59%] versus 34 of 79 [43%] patients with no MDO, and 10 of 19 [53%] with insufficient information to determine [ P =0.05]). Among patients with MDO, 34 of 37 (92%) had ≥1 documented medical encounter in the month preceding stroke diagnosis compared with 47 of 79 (59%) individuals without MDO and 9 of 19 (47%) with insufficient information to determine ( P 1 in 4 pregnant or postpartum patients with acute stroke experienced MDO. Our results suggest a need for enhanced clinician education, particularly for nonneurologists, in diagnosing stroke during pregnancy and the postpartum period.
- 1 February 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (2) , 292-300
Top Cited PapersIdentifying Missed Diagnostic Opportunities in Maternal Stroke
BACKGROUND: Pregnancy-associated stroke may present with nonfocal symptoms, leading to missed diagnostic opportunities (MDO). METHODS: We conducted a retrospective study including patients aged 18 to 50 years and pregnant or within 1 year of delivery, treated at 5 US comprehensive stroke centers from 2012 to 2021 for confirmed arterial ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, or cerebral venous thrombosis. Vascular neurologists at each site reviewed cases using a validated tool, Safer Stroke-Dx. We determined the proportion of cases with MDO and estimated 95% CIs based on a binomial distribution. RESULTS: We identified 135 patients with pregnancy-related stroke (mean age, 32.4 [SD, 6.0] years), of whom 37 (27%) had MDO (95% CI, 20.6%–35.5%). Presenting symptoms included focal neurological deficits (57%; n=77), headache (53%; n=71), systemic symptoms (26%; n=35), and altered mental status (19%; n=25). More patients with MDO had hemorrhagic strokes (22 of 37 [59%] versus 34 of 79 [43%] patients with no MDO, and 10 of 19 [53%] with insufficient information to determine [ P =0.05]). Among patients with MDO, 34 of 37 (92%) had ≥1 documented medical encounter in the month preceding stroke diagnosis compared with 47 of 79 (59%) individuals without MDO and 9 of 19 (47%) with insufficient information to determine ( P 1 in 4 pregnant or postpartum patients with acute stroke experienced MDO. Our results suggest a need for enhanced clinician education, particularly for nonneurologists, in diagnosing stroke during pregnancy and the postpartum period.
- 26 November 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (12) , 2372-2375
A National Institute on Aging workshop on the long-term effects of pregnancy on aging
- 26 November 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (12) , 2372-2375
A National Institute on Aging workshop on the long-term effects of pregnancy on aging
- 6 October 2025
- Published by SAGE Publications in Journal of Women's Health
- Vol. 34 (10) , 1195-1203
The Association Between Age of Menopause and Hysterectomy Status and Alzheimer’s Disease Risk in a Cohort of Older White and Black Women
Background and Objectives: To determine whether age at menopause and premenopausal hysterectomy status are associated with incident Alzheimer’s disease (AD) dementia in a group of older community-dwelling women. Materials and Methods: Participants from the Rush Memory and Aging Project, the Religious Orders Study, and the Minority Aging Research Study were included ( n = 2,862, baseline age 77.1 ± 7.7 years, follow-up 8.6 ± 5.6 years, 24% Black, and 75% White). Age at menopause and premenopausal hysterectomy status were based on self-report at study entry. AD dementia diagnosis was determined annually based on the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria. The hazard of AD dementia was evaluated using Cox-proportional regression models, with age as the time axis, adjusted for race, early life socioeconomic status, and education. To explore possible differences in risk by race, models were repeated using White and Black women propensity score-matched on age at baseline, education, and number of follow-up visits. Results: Menopause before age 45 years was associated with a 33% greater hazard of AD dementia compared with menopause after age 50 years (hazard ratio [HR] = 1.33, 95% confidence interval [CI]: 1.10–1.59). Hysterectomy was not associated with hazard of AD dementia (HR = 1.08, CI: 0.94–1.26). The association between age at menopause and hysterectomy status and AD dementia was not different for White and Black women. Conclusions: Some sex-specific menopausal characteristics, such as age at menopause, relate to the hazard of AD dementia. Given the disproportionate burden of AD in women, research is needed to explore potential mechanisms for this finding.
- 6 October 2025
- Published by SAGE Publications in Journal of Women's Health
- Vol. 34 (10) , 1195-1203
The Association Between Age of Menopause and Hysterectomy Status and Alzheimer’s Disease Risk in a Cohort of Older White and Black Women
Background and Objectives: To determine whether age at menopause and premenopausal hysterectomy status are associated with incident Alzheimer’s disease (AD) dementia in a group of older community-dwelling women. Materials and Methods: Participants from the Rush Memory and Aging Project, the Religious Orders Study, and the Minority Aging Research Study were included ( n = 2,862, baseline age 77.1 ± 7.7 years, follow-up 8.6 ± 5.6 years, 24% Black, and 75% White). Age at menopause and premenopausal hysterectomy status were based on self-report at study entry. AD dementia diagnosis was determined annually based on the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria. The hazard of AD dementia was evaluated using Cox-proportional regression models, with age as the time axis, adjusted for race, early life socioeconomic status, and education. To explore possible differences in risk by race, models were repeated using White and Black women propensity score-matched on age at baseline, education, and number of follow-up visits. Results: Menopause before age 45 years was associated with a 33% greater hazard of AD dementia compared with menopause after age 50 years (hazard ratio [HR] = 1.33, 95% confidence interval [CI]: 1.10–1.59). Hysterectomy was not associated with hazard of AD dementia (HR = 1.08, CI: 0.94–1.26). The association between age at menopause and hysterectomy status and AD dementia was not different for White and Black women. Conclusions: Some sex-specific menopausal characteristics, such as age at menopause, relate to the hazard of AD dementia. Given the disproportionate burden of AD in women, research is needed to explore potential mechanisms for this finding.